Neurological Biomarkers Market Size, Trends and Growth Analysis Report 2031

The global neurological biomarkers market size was valued at USD 7,823.39 million&nbsp;in 2022. It is estimated to reach USD 23,332.71 million&nbsp;by 2031, growing at a CAGR of 12.91% during the forecast period (2023&ndash;2031). Factors such as inc Report Scope:<table><tr><td>Report Metric</td><td>Details</td></tr><tr><td><strong>Study Period</strong></td><td>2019-2031</td></tr><tr><td><strong>Historical Period</strong></td><td>2019-2021</td></tr><tr><td><strong>Forecast Period</strong></td><td>2023-2031</td></tr><tr><td><strong>Base Year</strong></td><td>2022</td></tr><tr><td><strong>Base Year Market Size</strong></td><td>USD 7,823.39 Million </td></tr><tr><td><strong>Forecast Year</strong></td><td>2031</td></tr><tr><td><strong>Forecast Year Market Size</strong></td><td>USD 23332.71 Million</td></tr><tr><td><strong>Forecast Year CAGR</strong></td><td>12.91%</td></tr> <tr><td><strong>Largest Market</strong></td><td>North America</td></tr><tr><td><strong>Fastest Growing Market</strong></td><td>Europe</td></tr> </table>

全球神经生物标志物市场规模于2022年达到78.2339亿美元。预计到2031年将达到233.3271亿美元，在预测期内（2023年至2031年）的复合年增长率将达到12.91%。报告范围：

<table>
<tr>
<td>报告指标</td>
<td>详细信息</td>
</tr>
<tr>
<td><strong>研究周期</strong></td>
<td>2019-2031年</td>
</tr>
<tr>
<td><strong>历史周期</strong></td>
<td>2019-2021年</td>
</tr>
<tr>
<td><strong>预测周期</strong></td>
<td>2023-2031年</td>
</tr>
<tr>
<td><strong>基准年份</strong></td>
<td>2022年</td>
</tr>
<tr>
<td><strong>基准年份市场规模</strong></td>
<td>78.2339亿美元</td>
</tr>
<tr>
<td><strong>预测年份</strong></td>
<td>2031年</td>
</tr>
<tr>
<td><strong>预测年份市场规模</strong></td>
<td>233.3271亿美元</td>
</tr>
<tr>
<td><strong>预测年份复合年增长率</strong></td>
<td>12.91%</td>
</tr>
<tr>
<td><strong>最大市场</strong></td>
<td>北美</td>
</tr>
<tr>
<td><strong>增长最快的市场</strong></td>
<td>欧洲</td>
</tr>
</table>